CTR9 antibody (N-Term)
Quick Overview for CTR9 antibody (N-Term) (ABIN7468911)
Target
See all CTR9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity
- Human
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the N-terminus region of human CTR9. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: 293T , A431 , HeLa , HepG2
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.03 mg/mL
-
Buffer
- 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- CTR9 (RNA Polymerase-Associated Protein CTR9 Homolog (CTR9))
-
Alternative Name
- CTR9 homolog, Paf1/RNA polymerase II complex component
-
Background
-
Synonyms: CTR9 homolog, Paf1/RNA polymerase II complex component , SH2BP1 , TSBP , p150 , p150TSP
Background: CTR9, parafibromin (CDC73, MIM 607393), LEO1 (MIM 610507), and PAF1 (MIM 610506) form the PAF protein complex, which associates with the RNA polymerase II subunit POLR2A (MIM 180660) and with a histone methyltransferase complex (Rozenblatt-Rosen et al., 2005 [PubMed 15632063]).[supplied by OMIM]
-
Molecular Weight
- 134 kDa
-
Gene ID
- 9646
-
UniProt
- Q6PD62
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Stem Cell Maintenance
Target
-